Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dysgeusia | 4 | 2020 | 524 | 1.43 | Why? |
| Tuberculosis, Female Genital | 1 | 2018 | 3 | 0.76 | Why? |
| Streptomyces | 1 | 2019 | 51 | 0.76 | Why? |
| Candida tropicalis | 1 | 2017 | 21 | 0.72 | Why? |
| Interleukin-12 | 1 | 2019 | 156 | 0.71 | Why? |
| Skin Diseases, Bacterial | 1 | 2019 | 105 | 0.70 | Why? |
| Leishmaniasis | 1 | 2017 | 26 | 0.68 | Why? |
| Cerebral Infarction | 1 | 2020 | 245 | 0.66 | Why? |
| Abscess | 1 | 2019 | 234 | 0.63 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.61 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2019 | 323 | 0.57 | Why? |
| Antibodies, Monoclonal, Humanized | 6 | 2022 | 9335 | 0.55 | Why? |
| Influenza B virus | 1 | 2020 | 815 | 0.54 | Why? |
| Olfaction Disorders | 3 | 2020 | 3704 | 0.52 | Why? |
| Candidemia | 1 | 2017 | 353 | 0.50 | Why? |
| Orthomyxoviridae | 1 | 2021 | 1168 | 0.47 | Why? |
| Influenza, Human | 3 | 2021 | 10779 | 0.45 | Why? |
| Antitubercular Agents | 1 | 2018 | 775 | 0.45 | Why? |
| Diarrhea | 2 | 2020 | 2743 | 0.44 | Why? |
| France | 8 | 2021 | 12074 | 0.43 | Why? |
| Recurrence | 1 | 2021 | 3675 | 0.43 | Why? |
| Lymphadenopathy | 1 | 2017 | 444 | 0.43 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.37 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.35 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.35 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.33 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.32 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.32 | Why? |
| Pharyngitis | 2 | 2020 | 687 | 0.31 | Why? |
| Tunisia | 2 | 2018 | 543 | 0.30 | Why? |
| Vomiting | 2 | 2020 | 722 | 0.29 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.26 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.24 | Why? |
| Retrospective Studies | 11 | 2020 | 105322 | 0.21 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.21 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.21 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.20 | Why? |
| Headache | 2 | 2020 | 2257 | 0.20 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.17 | Why? |
| Meningitis, Bacterial | 1 | 2018 | 111 | 0.17 | Why? |
| Adult | 12 | 2021 | 244371 | 0.16 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.16 | Why? |
| Nausea | 1 | 2020 | 457 | 0.16 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.16 | Why? |
| Amphotericin B | 1 | 2017 | 256 | 0.15 | Why? |
| Voriconazole | 1 | 2017 | 206 | 0.15 | Why? |
| Male | 15 | 2021 | 367725 | 0.15 | Why? |
| Meningoencephalitis | 1 | 2018 | 208 | 0.15 | Why? |
| Herpesvirus 1, Human | 1 | 2018 | 286 | 0.15 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.15 | Why? |
| Herpes Simplex | 1 | 2018 | 272 | 0.14 | Why? |
| Humans | 23 | 2022 | 930598 | 0.14 | Why? |
| Neck | 1 | 2017 | 307 | 0.14 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.14 | Why? |
| Abdominal Pain | 1 | 2020 | 858 | 0.13 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.13 | Why? |
| Female | 13 | 2021 | 380317 | 0.13 | Why? |
| Aged | 9 | 2021 | 215776 | 0.13 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.11 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.10 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.10 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.09 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.08 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.08 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.08 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.06 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Suppuration | 1 | 2018 | 8 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Child | 1 | 2021 | 70012 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Zayet's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_